MRL/lpr mice, which develop spontaneous lupus-like autoimmune disease, had higher levels of serum IL-18 compared to controls (76), and the mice treated with IL-18 developed accelerated proteinuria, glomerulonephritis and vasculitis (76). This evidence concerns the gene IL18 and systemic lupus erythematosus.